The stocks most investors skipped over are now the ones leading the market. After five straight years of underperformance, small-caps are finally beating large ones — and microcaps, the tiniest tier of all, are outpacing even those. Increasingly, investors are betting that the least-covered companies offer the greatest opportunities.

• Bridgeway’s Ultra-Small Company FundBRSIX
  surged 63% in the past year — outpacing the Russell 2000’s 42% and doubling the S&P 500.
• The rally comes as reshoring and tax incentives favor domestic investment — delivering outsized earnings growth for companies too small to rely on global supply chains.

Analyst blind spot: Microcaps are what Royce Investment Partners calls “a highly inefficient asset class,” with many companies receiving zero analyst coverage. Morningstar’s research backs that up, showing active managers outperform passive more consistently here than in most categories. Funds in the space have been finding their edge in undiscovered AI infrastructure plays and “boring” medical device suppliers — the kind of names that fly under Wall Street’s radar by design. The catch with undiscovered stocks, though, is that they don’t stay that way for long.